An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nature Medicine

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2100PMID 20154697PMCID PMC2903662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer.

  2019cited by this paper
• The Biology of Cancer

  2015cited by this paper
• Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis

  2009cited by this paper
• Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

  2009cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Shared principles in NF-kappaB signaling.

  2008cited by this paper
• NF-kappaB and cancer-identifying targets and mechanisms.

  2008cited by this paper
• BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma

  2008cited by this paper
• Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

  2008cited by this paper
• Roles of the EZH2 histone methyltransferase in cancer epigenetics.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Pten inactivation and the emergence of androgen-independent prostate cancer.

  2007cited by this paper
• GEFs in growth factor signaling

  2007cited by this paper
• A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.

  2007cited by this paper
• Adaptation versus selection: the origins of metastatic behavior.

  2007cited by this paper
• BRAF and KRAS mutations in prostatic adenocarcinoma

  2006cited by this paper
• Recent progress in hormonal therapy for advanced prostate cancer

  2006cited by this paper
• Integrative biology of prostate cancer progression.

  2006cited by this paper
• Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

  2005cited by this paper
• The NF1 tumor suppressor critically regulates TSC2 and mTOR.

  2005cited by this paper
• Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers

  2005cited by this paper
• GAPs in growth factor signalling

  2005cited by this paper
• Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer*

  2005cited by this paper
• Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

  2004cited by this paper
• Identification of a novel RAS GTPase‐activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia

  2004cited by this paper
• Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage

  2004cited by this paper
• Epithelial-mesenchymal transition: NF-kappaB takes center stage.

  2004cited by this paper
• AIP1/DAB2IP, a Novel Member of the Ras-GAP Family, Transduces TRAF2-induced ASK1-JNK Activation*

  2004cited by this paper
• Aberrant Promoter Methylation in Human DAB2 Interactive Protein (hDAB2IP) Gene in Breast Cancer

  2004cited by this paper
• Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.

  2003cited by this paper
• Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines* 210

  2003cited by this paper
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

  2003cited by this paper
• Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

  2002cited by this paper
• Gene expression analysis of prostate cancers

  2002cited by this paper
• Mouse models of prostate carcinogenesis.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

  2002cited by this paper
• Prognosis of cancers associated with venous thromboembolism.

  2000cited by this paper
• Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κB

  2000cited by this paper
• Activation of mitogen-activated protein kinase associated with prostate cancer progression.

  1999cited by this paper
• Radical Prostatectomy for Clinically Localized Prostate Cancer: local Tumor Extension and Prognosis

  1996cited by this paper
• Neurofibromatosis: Phenotype, Natural History and Pathogenesis

  1993cited by this paper
• Activated ras alleles in human carcinoma of the prostate are rare.

  1991cited by this paper
• ras gene mutations in human prostate cancer.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper

• Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors.

  2025cites this paper
• ATAD2 Drives Prostate Cancer Progression to Metastasis.

  2025cites this paper
• Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance

  2025cites this paper
• Linking Megalin, Cubilin, Caveolin-1, GIPC1 and Dab2IP Expression to Ocular Tumorigenesis: Profiles in Retinoblastoma, Choroidal Melanoma, and the Normal Human Eye

  2025cites this paper
• Network Topology Similarities Across Cancer Types: Identifying Central Protein Hubs for Drug Discovery

  2025cites this paper
• Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer.

  2025cites this paper
• A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review

  2025cites this paper
• Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

  2025cites this paper
• The role of ubiquitination and deubiquitination in urological tumours

  2025cites this paper
• Nuclear DAB2IP regulates DNA replication initiation through activating PLK1-mediated HBO1 phosphorylation

  2025cites this paper
• RETRACTED ARTICLE: The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression

  2024cites this paper
• Drug-Repurposing Screen Identifies Thiostrepton as a Novel Regulator of the Tumor Suppressor DAB2IP

  2024cites this paper
• EZH2 Activates HTLV‐1 bZIP Factor‐Mediated TGF‐β Signaling in Adult T‐Cell Leukemia

  2024cites this paper
• Exploring Lung Cancer Protein Network: Understanding Structure and Function through Metric Space Modeling

  2024cites this paper
• RETRACTED ARTICLE: Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle

  2024cites this paper
• Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells

  2024cites this paper
• Exploring the Genetic Landscape of Vitiligo in the Pura Raza Español Horse: A Genomic Perspective

  2024cites this paper
• Dysregulation of deubiquitination in breast cancer.

  2024cites this paper
• Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer

  2024cites this paper
• An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications

  2024cites this paper
• Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients

  2024cites this paper
• RETRACTED ARTICLE: Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution

  2024cites this paper
• PEN-coated superparamagnetic iron-mediated delivery of siSnail2 to inhibit metastasis and promote ferroptosis in the treatment of cancer.

  2023cites this paper
• Polycomb repressor complex: Its function in human cancer and therapeutic target strategy.

  2023cites this paper
• Epigenetic markers and therapeutic targets for metastasis

  2023cites this paper
• Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC

  2023cites this paper
• EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer.

  2023cites this paper
• DAB2IP stabilizes p27Kip1 via suppressing PI3K/AKT signaling in clear cell renal cell carcinoma

  2023cites this paper
• Germline variation in RASAL2 may predict survival in patients with RAS ‐activated colorectal cancer

  2023cites this paper
• Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?

  2023cites this paper
• Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia

  2023cites this paper
• DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer

  2023influential citation
• Downregulation of EZH2 inhibits epithelial–mesenchymal transition in enzalutamide‐resistant prostate cancer

  2023cites this paper
• Neuronal Histone Methyltransferase EZH2 Regulates Neuronal Morphogenesis, Synaptic Plasticity, and Cognitive Behavior in Mice

  2023cites this paper
• RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis

  2022cites this paper
• circEZH2E2 /E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression

  2022cites this paper
• Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein.

  2022cites this paper
• DAB2IP regulates intratumoral testosterone synthesis and CRPC tumor growth by ETS1/AKR1C3 signaling.

  2022cites this paper
• Enhancer reprogramming promotes the activation of cancer-associated fibroblasts and breast cancer metastasis

  2022cites this paper
• DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.

  2022cites this paper
• Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer

  2021cites this paper
• A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer

  2021cites this paper
• Going beyond Polycomb: EZH2 Functions in Prostate Cancer

  2021cites this paper
• Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies

  2021cites this paper
• Genetic Impairments of PRC2 Activity in Oncology: Problems and Prospects

  2021cites this paper
• microRNA-1266-5p directly targets DAB2IP to enhance oncogenicity and metastasis in oral cancer

  2021cites this paper
• The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials

  2021cites this paper
• Lipid metabolism part I

  2021cites this paper
• Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex

  2021cites this paper
• Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers

  2021cites this paper
• The roles of epigenetics in cancer progression and metastasis.

  2021cites this paper
• PRKAA/AMPKα phosphorylation switches the role of RASAL2 from a suppressor to an activator of autophagy

  2021cites this paper
• Lipid metabolism part II

  2021cites this paper
• TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway

  2020cites this paper
• USP7 stabilizes EZH2 and enhances cancer malignant progression.

  2020cites this paper
• Decitabine Reverses CSC-Induced Docetaxel Resistance via Epigenetic Regulation of DAB2IP in TNBC.

  2020cites this paper
• Pumping the brakes on RAS – negative regulators and death effectors of RAS

  2020influential citation
• Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis

  2020cites this paper
• DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway CURRENT POSTED

  2020cites this paper
• Cutting the Brakes on Ras—Cytoplasmic GAPs as Targets of Inactivation in Cancer

  2020cites this paper
• SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.

  2020cites this paper
• Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine

  2020cites this paper
• USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells

  2020cites this paper
• EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells

  2020influential citation
• Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis

  2020cites this paper
• Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells

  2020cites this paper
• Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?

  2020cites this paper
• Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications

  2020cites this paper
• miR‐451a is downregulated and targets PSMB8 in prostate cancer

  2020cites this paper
• Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.

  2020cites this paper
• Phenotypic plasticity and lineage switching in prostate cancer

  2020cites this paper
• Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review).

  2020cites this paper
• HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study

  2020cites this paper
• Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression

  2020cites this paper
• DEUBIQUITINATING ENZYMES PROMOTE CANCER PROGRESSION AND METASTASIS VIA REGULATING PROTEIN STABILITY

  2019cites this paper
• Targeting epigenetic machinery: Emerging novel allosteric inhibitors.

  2019cites this paper
• Short AIP1 (ASK1-Interacting Protein-1) Isoform Localizes to the Mitochondria and Promotes Vascular Dysfunction.

  2019cites this paper
• SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170.

  2019cites this paper
• DAB2IP Expression in Abdominal Aortic Aneurysm: EZH2 and mir-363-3p as Potential Mediators

  2019cites this paper
• Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer

  2019cites this paper
• EGR1 Regulates Angiogenic and Osteoclastogenic Factors in Prostate Cancer and Promotes Metastasis

  2019cites this paper
• HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer

  2019cites this paper
• Targeting Cancer at the Intersection of Signaling and Epigenetics

  2019cites this paper
• The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells

  2019cites this paper
• Neuronal histone methyltransferase EZH2 regulates neuronal morphogenesis, synaptic plasticity, and cognitive behavior of mice

  2019cites this paper
• Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

  2019cites this paper
• The functions and regulations of Smurfs in cancers.

  2019cites this paper
• CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition

  2019cites this paper
• CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression

  2019cites this paper
• Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas

  2019cites this paper
• Enhancer of zeste homolog 2 enhances the migration and chemotaxis of dental mesenchymal stem cells

  2019cites this paper
• Cigarette smoke affects the onco-suppressor DAB2IP expression in bronchial epithelial cells of COPD patients

  2019cites this paper
• Therapeutic Targeting of Chromatin Modifiers in Advanced Prostate Cancer

  2019influential citation
• Disabled homolog 2 interactive protein functions as a tumor suppressor in osteosarcoma cells

  2018cites this paper
• Epigenetic Regulation in Prostate Cancer Progression

  2018cites this paper
• RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer

  2018cites this paper
• Co-targeting kinases and epigenetic regulators for the treatment of Ras-driven lung cancer

  2018cites this paper
• ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.

  2018cites this paper
• MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

  2018cites this paper